| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vor Biopharma Inc. | CFO | Common Stock | 0 | $0 | $7.96 | 05 Dec 2025 | Direct |
| Vor Biopharma Inc. | CFO | Employee Stock Option (right to buy) | 1,388,274 | 05 Dec 2025 | Direct | ||
| Aeglea BioTherapeutics, Inc. | Director | Director Stock Option (right to buy) | 43,000 | 07 Jun 2022 | Direct | ||
| CRISPR Therapeutics AG | Director | Stock Option (Right to Buy) | 13,000 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VOR | Vor Biopharma Inc. | 05 Dec 2025 | 2 | $0 | 4 | CFO | 09 Dec 2025, 08:00 |
| VOR | Vor Biopharma Inc. | 09 Jul 2025 | 1 | $0 | 4 | CFO | 10 Jul 2025, 16:51 |
| VOR | Vor Biopharma Inc. | 09 Jul 2025 | 0 | $0 | 3 | CFO | 10 Jul 2025, 16:49 |
| CRSP | CRISPR Therapeutics AG | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 17:30 |
| CRSP | CRISPR Therapeutics AG | 30 May 2024 | 1 | $0 | 4 | Director | 31 May 2024, 16:15 |
| CRSP | CRISPR Therapeutics AG | 30 May 2024 | 0 | $0 | 3 | Director | 30 May 2024, 16:27 |
| SYRE | Aeglea BioTherapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 21:18 |
| SYRE | Aeglea BioTherapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 09 Jun 2021, 17:26 |